Bruderman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bruderman Asset Management's BMY Position: Q4 2021 in Review
Bruderman Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 98,772 shares — an estimated $5.84M sold.
Bruderman Asset Management first reported a position in BMY in Q1 2015 and held it in 19 quarters. The position peaked at $9.71M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Bruderman Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- Bruderman Asset Management sold 98,772 Bristol-Myers Squibb shares in Q4 2021, an estimated $5.84M.
- Bruderman Asset Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 19 quarters.
- Bruderman Asset Management's Bristol-Myers Squibb position peaked at $9.71M in Q2 2021.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Bruderman Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.